WB
SNDX icon

WesBanco Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

WesBanco Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$809K Hold
37,000
– – 0.02% 420
2026
Q1 		$864K Hold
37,000
– – 0.02% 395
2025
Q4 		$777K Buy
+37,000
New +$645K 0.02% 402

Other funds holding SNDX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VIG
Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

WesBanco Bank's SNDX Position: Q2 2026 in Review

WesBanco Bank held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 37,000 shares worth $809K. The position accounts for 0.02% of the portfolio, ranked #420.

WesBanco Bank first reported a position in SNDX in Q4 2025 and has held it in 3 quarters since. The position peaked at $864K in Q1 2026. 36 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • WesBanco Bank held 37,000 shares of Syndax Pharmaceuticals worth $809K as of Q2 2026.
  • WesBanco Bank left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up 0.02% of WesBanco Bank's portfolio in Q2 2026, its #420 holding.
  • WesBanco Bank first reported a position in Syndax Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • WesBanco Bank's Syndax Pharmaceuticals position peaked at $864K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.